6 completed, 1 recruiting. 7 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 7 | Completed 6, Recruiting 1 |
| Phase 2 | 1 | Completed 1 |
Follow Piperacillin-tazobactam: new trials by email Literature Review of Piperacillin-tazobactam trials Research Report on Piperacillin-tazobactam
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Continuous Antibiotic Infusion In Children Benzylpenicillin - Infection | Phase 3 | Recruiting | Tampere University Hospital | 150 | 2026-04-21 | 2026-05-08 |
| Does Cefoxitin or Piperacillin-Tazobactam Prevent Postoperative Surgical Site Infections After Pancreatoduodenectomy? Cefoxitin, Piperacillin-tazobactam - Pancreatic Cancer, Pancreas Cancer | Phase 3 | Completed | Memorial Sloan Kettering Cancer Center | 967 | 2017-11-21 | 2025-10-21 |
| PK/PD of Extended-infusion Meropenem, Piperacillin-tazobactam and Cefepime in the Early Phase of Septic Shock MEROPENEM, PIPERACILLIN-TAZOBACTAM, CEFEPIME - Septic Shock | Phase 3 | Completed | Centre Hospitalier Universitaire de Besancon | 119 | 2016-09-27 | 2025-01-16 |
| Safety and Efficacy of ZTI-01 (IV Fosfomycin) vs Piperacillin/Tazobactam for Treatment cUTI/AP Infections ZTI-01, Piperacillin-tazobactam - Urinary Tract Infection Symptomatic, Acute Pyelonephritis | Phase 2 / Phase 3 | Completed | Nabriva Therapeutics AG | 465 | 2016-04-01 | 2019-03-07 |
| Efficacy/Safety of Meropenem-Vaborbactam Compared to Piperacillin-Tazobactam in Adults With cUTI and AP Meropenem-Vaborbactam, Piperacillin-Tazobactam, Levofloxacin - Urinary Tract Infection Complicated, Acute Pyelonephritis | Phase 3 | Completed | Melinta Therapeutics, Inc. | 550 | 2014-11-20 | 2018-06-11 |
| Piperacllin Versus Placebo in Patients Undergoing Surgery for Acute Cholecystitis Piperacillin-tazobactam combination product, Saline solution - Cholecystitis, Acute | Phase 3 | Completed | Karolinska Institutet | 100 | 2009-03-01 | 2018-03-06 |
| Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count piperacillin sodium, piperacillin-tazobactam, tazobactam sodium - Bone Marrow Suppression, Fever, Sweats, and Hot Flashes | Phase 3 | Completed | European Organisation for Research and Treatment of Cancer - EORTC | 859 | 1997-11-01 | 2012-09-24 |
Infections (2) · Blast Crisis (1) · Burkitt Lymphoma (1) · Cholecystitis, Acute (1) · Dendritic Cell Sarcoma, Interdigitating (1) · Fever (1) · Hodgkin Disease (1) · Hot Flashes (1) · Leukemia (1) · Leukemia, Hairy Cell (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Leukemia, Myeloid, Accelerated Phase (1) · Leukemia, Myeloid, Acute (1) · Leukemia, Myeloid, Chronic-Phase (1) · Lymphoma (1)
Centre Hospitalier Universitaire de Besancon (1) · European Organisation for Research and Treatment of Cancer - EORTC (1) · Karolinska Institutet (1) · Melinta Therapeutics, Inc. (1) · Memorial Sloan Kettering Cancer Center (1) · Nabriva Therapeutics AG (1) · Tampere University Hospital (1)
United States (4) · Czechia (3) · Greece (3) · Slovakia (3) · Belarus (2) · Bulgaria (2) · Canada (2) · Finland (2) · France (2) · Hungary (2) · Poland (2) · Romania (2) · Ukraine (2) · Belgium (1) · Brazil (1)
Evelyn J Ellis-Grosse, PhD (1) · Folke Hammarqvist, Ass Prof (1) · Karen Fusaro (1) · Keith Kaye (1) · Michael D'Angelica, MD (1) · Michel P. Glauser, MD (1)
PMID 20594297, PMID 29486041, PMID 30861061, PMID 32860109, PMID 33664081, PMID 34768176, PMID 37078771
2015 (1), 2025 (1)